2025-10-31 23:39:42
Latest Post
Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores
Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore
LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore
NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects
Lemon Tree Hotels signs 11th property in Punjab
Stock Report
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Posted On : 2025-10-31 16:47:23( TIMEZONE : IST )
Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended September 30, 2025.
Financial Results (Q2 FY2026) - QoQ Comparison
The company has reported total income of Rs. 124.524 crores during the period ended September 30, 2025 as compared to Rs. 118.019 crores during the period ended June 30, 2025.
The company has posted net profit / (loss) of Rs. 9.917 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 6.651 crores for the period ended June 30, 2025.
The company has reported EPS of Rs. 4.24 for the period ended September 30, 2025 as compared to Rs. 2.84 for the period ended June 30, 2025.
| Financials | Q2 FY2026 | Q1 FY2026 | % Change |
| Total Income | ₹124.524 crs | ₹118.019 crs |  5.51% |
| Net Profit | ₹9.917 crs | ₹6.651 crs | 49.11% |
| EPS | ₹4.24 | ₹2.84 | 49.30% |
Financial Results (Q2 FY2026) - YoY Comparison
The company has reported total income of Rs.124.524 crores during the period ended September 30, 2025 as compared to Rs.83.867 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.9.917 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.-0.664 crores for the period ended September 30, 2024.
The company has reported EPS of Rs.4.24 for the period ended September 30, 2025 as compared to Rs.-0.29 for the period ended September 30, 2024.
| Financials | Q2 FY2026 | Q2 FY2025 | % Change |
| Total Income | ₹124.524 crs | ₹83.867 crs | 48.48% |
| Net Profit | ₹9.917 crs | ₹-0.664 crs | 1,593.52% |
| EPS | ₹4.24 | ₹-0.29 | 1,562.07% |
Financial Results (Half Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.242.543 crores during the 6 Months period ended September 30, 2025 as compared to Rs.190.504 crores during the 6 Months period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.16.568 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.4.545 crores for the 6 Months period ended September 30, 2024.
The company has reported EPS of Rs.7.08 for the 6 Months period ended September 30, 2025 as compared to Rs.1.94 for the 6 Months period ended September 30, 2024.
| Financials | Half Year Ended FY2026 | Half Year Ended FY2025 | % Change |
| Total Income | ₹242.543 crs | ₹190.504 crs | 27.32% |
| Net Profit | ₹16.568 crs | ₹4.545 crs | 264.53% |
| EPS | ₹7.08 | ₹1.94 | 264.95% |
Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 1356.50 as compared to the previous close of Rs. 1371.60. The total number of shares traded during the day was 3701 in over 307 trades.
The stock hit an intraday high of Rs. 1378.10 and intraday low of 1351.20. The net turnover during the day was Rs. 5043248.00.
